Device Trial Radar · NCT04584619
Idys™ TLIF 3DTi Post Market Clinical Follow-up
Last checked: Nov 20, 2026Latest source record: Nov 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
25
Planned (sponsor's estimate)
Start
Oct 1, 2020
Primary completion
Sep 30, 2023
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- ClarianceNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 14, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this observational post-marketing study is to provide additional information on the safety and effectiveness of Idys™ TLIF 3DTi at up to 24 months post transforaminal lumbar fusion in usual surgical practice.
Conditions
- Degenerative Disc Disease
- Grade 1 Spondylolisthesis
Interventions
Spine fusion surgery with Clariance Idys TLIF 3DTiDevice
Posterior fusion of the lumbar spine with Clariance Idys TLIF 3DTi interbody fusion device used in conjunction with a posterior fixation system (pedicle screws and rod).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evolution of the Fusion rateTime frame: 6 months, 12 months, 24 months postoperatively
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Brazos Spine
College Station, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.